Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Neratinib fda approval date indications?How expensive is dupixent?Sodium potassium magnesium sulfate colonoscopy prep?Neratinib fda approval july 2017?Auvelity approval europe 2024?
See the DrugPatentWatch profile for Vyvanse
Vyvanse’s active ingredient is lisdexamfetamine dimesylate (often written as lisdexamfetamine).
Lisdexamfetamine dimesylate is a prodrug: after you take Vyvanse, your body converts it into dextroamphetamine, the pharmacologically active stimulant that affects dopamine and norepinephrine signaling.
Vyvanse contains lisdexamfetamine (a prodrug form of dextroamphetamine). Adderall contains mixed amphetamine salts rather than lisdexamfetamine.
When people ask about Vyvanse’s ingredient, they usually mean the active drug (lisdexamfetamine dimesylate), not fillers or inactive components in the tablet/capsule.
Other Questions About Vyvanse :